<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16-viruses-12-00240">
 <label>16.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kumar</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Shin</surname>
    <given-names>J.S.</given-names>
   </name>
   <name>
    <surname>Shie</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Ku</surname>
    <given-names>K.B.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Go</surname>
    <given-names>Y.Y.</given-names>
   </name>
   <name>
    <surname>Huang</surname>
    <given-names>K.F.</given-names>
   </name>
   <name>
    <surname>Kim</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Liang</surname>
    <given-names>P.H.</given-names>
   </name>
  </person-group>
  <article-title>Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CL(Pro) inhibitors</article-title>
  <source>Antivir. Res.</source>
  <year>2017</year>
  <volume>141</volume>
  <fpage>101</fpage>
  <lpage>106</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2017.02.007</pub-id>
  <pub-id pub-id-type="pmid">28216367</pub-id>
 </element-citation>
</ref>
